These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 2629652)
1. [Pharmacokinetic monitoring during aminoglycoside treatment: the optimal method for individualizing the dosage of tobramycin]. Firsov AA; Manuĭlov KK; Fomina IP; Lukomskiĭ GI; Alekseeva ME Antibiot Khimioter; 1989 Dec; 34(12):915-20. PubMed ID: 2629652 [TBL] [Abstract][Full Text] [Related]
2. Suboptimal aminoglycoside dosing in critically ill patients. Rea RS; Capitano B; Bies R; Bigos KL; Smith R; Lee H Ther Drug Monit; 2008 Dec; 30(6):674-81. PubMed ID: 19057371 [TBL] [Abstract][Full Text] [Related]
3. Effect of pharmacokinetic sampling methods on aminoglycoside dosing in critically ill surgery patients. Mann HJ; Wittbrodt ET; Baghaie AA; Cerra FB Pharmacotherapy; 1998; 18(2):371-8. PubMed ID: 9545157 [TBL] [Abstract][Full Text] [Related]
4. Monitoring of a single post-infusion blood sample to estimate the actual peak and trough concentration of tobramycin in critically ill patients. Reimann IR; Meier-Hellmann A; Traut T; Reinhart K; Hoffmann A Exp Toxicol Pathol; 2003 Jun; 54(5-6):493-8. PubMed ID: 12877363 [TBL] [Abstract][Full Text] [Related]
5. Comparing dosage adjustment methods for once-daily tobramycin in paediatric and adolescent patients with cystic fibrosis. Hennig S; Holthouse F; Staatz CE Clin Pharmacokinet; 2015 Apr; 54(4):409-21. PubMed ID: 25403847 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetic variability of extended interval tobramycin in burn patients. Bracco D; Landry C; Dubois MJ; Eggimann P Burns; 2008 Sep; 34(6):791-6. PubMed ID: 18395988 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic modelling of intravenous tobramycin in adolescent and adult patients with cystic fibrosis using the nonparametric expectation maximization (NPEM) algorithm. Touw DJ; Vinks AA; Neef C Pharm World Sci; 1997 Jun; 19(3):142-51. PubMed ID: 9259030 [TBL] [Abstract][Full Text] [Related]
14. Tobramycin pharmacokinetics in patients with cystic fibrosis before and after bilateral lung transplantation. Walsh KA; Davis GA; Hayes D; Kuhn RJ; Weant KA; Flynn JD Transpl Infect Dis; 2011 Dec; 13(6):616-21. PubMed ID: 21794042 [TBL] [Abstract][Full Text] [Related]
15. Wide variation in single, daily-dose aminoglycoside pharmacokinetics in patients with burn injuries. Hoey LL; Tschida SJ; Rotschafer JC; Guay DR; Vance-Bryan K J Burn Care Rehabil; 1997; 18(2):116-24. PubMed ID: 9095420 [TBL] [Abstract][Full Text] [Related]
16. Modification of Diet in Renal Disease and modified Cockcroft-Gault formulas in predicting aminoglycoside elimination. Bookstaver PB; Johnson JW; McCoy TP; Stewart D; Williamson JC Ann Pharmacother; 2008 Dec; 42(12):1758-65. PubMed ID: 19047358 [TBL] [Abstract][Full Text] [Related]
17. Determination of tobramycin pharmacokinetics in burn patients to evaluate the potential utility of once-daily dosing in this population. Vella D; Walker SA; Walker SE; Daneman N; Simor A J Burn Care Res; 2014; 35(4):e240-9. PubMed ID: 24043237 [TBL] [Abstract][Full Text] [Related]
18. Tobramycin pharmacokinetics in children with febrile neutropenia undergoing stem cell transplantation: once-daily versus thrice-daily administration. Dupuis LL; Sung L; Taylor T; Abdolell M; Allen U; Doyle J; Taddio A Pharmacotherapy; 2004 May; 24(5):564-73. PubMed ID: 15162890 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic studies on tobramycin in horses. Hubenov H; Bakalov D; Krastev S; Yanev S; Haritova A; Lashev L J Vet Pharmacol Ther; 2007 Aug; 30(4):353-7. PubMed ID: 17610409 [TBL] [Abstract][Full Text] [Related]
20. Assessment of aminoglycoside dosing and estimated glomerular filtration rate in determining gentamicin and tobramycin area under the curve and clearance. Lim AK; Mathanasenarajah G; Larmour I Intern Med J; 2015 Mar; 45(3):319-29. PubMed ID: 25581282 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]